Stoke Therapeutics Inc Sustainability Reports
Stoke Therapeutics, Inc. is a biotechnology company focused on developing RNA-based medicines to treat severe genetic diseases. The company utilizes its proprietary TANGO platform to restore target protein expression levels in individuals with gene-based haploinsufficiencies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300RD25SS2DIJHJ67
FIGI: BBG00JPCBPH8
3 reports from 2020 to 2025